Author

Lukas Scheibler

Apellis Pharmaceuticals (United States)ORCID 0009-0002-1188-1918Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:rat· 1

Frequent Co-Authors

Anja Kristina SchöttleriD· 1 shared Britt Arets· 1 shared David J. EyermaniD· 1 shared Erik Richardson· 1 shared Marc H. De BaetsiD· 1 shared Marina Mané-Damas· 1 shared Mario H. LoseniD· 1 shared Pilar Martínez‐MartíneziD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anja Kristina SchöttlerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintAug 31, 2025

Complement inhibition by C3-siRNA treatment prevents AChR loss and reduces complement activation in the rat Passive Transfer Myasthenia Gravis (PTMG)

Anja Kristina Schöttler, Marina Mané-Damas, Britt Arets…·Pilar Martínez‐Martínez

C3-siRNA treatment in PTMG rats reduces AChR loss and MAC deposition, improving muscle function and suggesting complement inhibition as a therapeutic strategy for AChR-MG.

DOI 10.1101/2025.08.31.673367

ratexperimental assay

𝕏 PostBluesky